198 related articles for article (PubMed ID: 29766398)
1. Hepatosplenic T cell lymphoma: a unifying entity in a patient with hemolytic anemia, massive splenomegaly, and liver dysfunction.
Mavilia M; McAuliffe A; Hafeez S; Vaziri H
Clin J Gastroenterol; 2018 Oct; 11(5):364-370. PubMed ID: 29766398
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
[TBL] [Abstract][Full Text] [Related]
3. Hepatosplenic T-cell lymphoma is a distinct rare entity: diagnosis by fine-needle aspiration cytology.
Kumar R; Dey P; Das A; Sachdeva MS; Varma S
Diagn Cytopathol; 2011 Sep; 39(9):677-80. PubMed ID: 21837655
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic T-cell lymphoma presented with massive splenomegaly and pancytopenia - a case report.
Sukrisman L; Rajabto W; Harahap AS; Fanggidae ESDE; Ham MF; Priantono D
Klin Onkol; 2023; 36(3):246-250. PubMed ID: 37353354
[TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
[TBL] [Abstract][Full Text] [Related]
6. Prolonged fever with pancytopenia and massive hepatosplenomegaly.
Sharma R; Yadav A; Mastebhakti B
Natl Med J India; 2023; 36(2):95-96. PubMed ID: 38692598
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
[TBL] [Abstract][Full Text] [Related]
8. Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly.
Lladó AC; Tomé AL; Henrique M; Farinha P
BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25012882
[TBL] [Abstract][Full Text] [Related]
9. Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity.
Siraj F; Dalal V; Khan AA; Jain D
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26481866
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia.
Lai R; Larratt LM; Etches W; Mortimer ST; Jewell LD; Dabbagh L; Coupland RW
Am J Surg Pathol; 2000 Mar; 24(3):459-63. PubMed ID: 10716161
[TBL] [Abstract][Full Text] [Related]
11. [Hemophacocytic syndrome as early sign for hepatosplenic T-cell lymphoma in a patient with chronic lymphocytic leukaemia].
Picque M; Khoury E; Lenoble M; Chait Y
Ann Biol Clin (Paris); 2014; 72(2):241-4. PubMed ID: 24736146
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
Ochenrider MG; Patterson DJ; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
[TBL] [Abstract][Full Text] [Related]
13. Malignant lymphoma without lymphadenopathy.
Kini U; Alexander B; Correa M
J Assoc Physicians India; 2008 May; 56():383-5. PubMed ID: 18700647
[TBL] [Abstract][Full Text] [Related]
14. F-18 flourodeoxyglucose positron emission tomography/computed tomography findings in a case of hepatosplenic T-cell lymphoma.
Joshi PV; Lele VR; Bhat GM; Garg S; Chitale A
J Cancer Res Ther; 2012; 8(1):106-8. PubMed ID: 22531524
[TBL] [Abstract][Full Text] [Related]
15. Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma.
Munir J; Preston G; Polish R
Hawaii Med J; 2004 Nov; 63(11):341-3. PubMed ID: 15633661
[TBL] [Abstract][Full Text] [Related]
16. Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
Brinkert F; Arrenberg P; Krech T; Grabhorn E; Lohse A; Schramm C
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27516526
[TBL] [Abstract][Full Text] [Related]
17. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A; Prindiville T
J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.
Yabe M; Medeiros LJ; Daneshbod Y; Davanlou M; Bueso-Ramos CE; Moran EJ; Young KH; Miranda RN
Ann Diagn Pathol; 2017 Feb; 26():16-22. PubMed ID: 28038706
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
